A week ago, the White House confirmed President Obama’s intentions to “fulfill his constitutional responsibility to nominate a successor to Justice Scalia.” The President echoed those words a day later, promising to provide the Senate with an “indisputably qualified” nominee. For their . . . . Continue Reading »
Cowboys and Indians, boys and girls, Commonweal and First Things: some rivalries are so elemental that a truce could only be a disappointment. Continue Reading »
Not enough has been said about how Pope Francis—a man of strong intuitions and vivid language—lives in and has been formed by literature. He regularly cites and recommends imaginative works like José Hernández’s Martín Fierro, Robert Hugh Benson’s Lord of the World, and Alessandro Manzoni’s The Betrothed. And he thinks by their patterns. Whereas Benedict strove for a concise, clear scholarly expression, Francis seeks the striking images and strong characterizations of the storyteller. Over here are the good guys, over there the bad. Continue Reading »
Very few of us who truly care about religious freedom in America would put our faith in a civic religion. Although 2,000 years of history can offer us many shining examples of church cooperating with state, the idea of a “state church” would be almost laughable in our country today. When I . . . . Continue Reading »
In an election year when reality seems as remote as a Pluto flyby; a year already marked by bombastic promises of walls, jobs, “a future to believe in” and free stuff for everybody, maybe we should take a quick break from the narcoleptic snooze imposed on us by the mass media. And maybe we . . . . Continue Reading »
From the Art of the Beautiful lecture series, to summer seminars organized by the Elm Institute, we've got you covered for events coming up in NYC and beyond.
A few months ago, BBC News suggested that “Martin Shkreli, the 32-year-old chief executive of Turing Pharmaceuticals, may be the most hated man in America right now.” That's because Turing, under Shkreli's watch, increased the price of a drug called Daraprim from $13.50 to $750 per tablet . . . . Continue Reading »